Discover Andy Brown's long and arduous journey battling a type of non-Hodgkin lymphoma and how a clinical trial altered his ...
Not a lot went down on the biotech deals front in August 2026, but it did see sustained collaboration in oncology and ...
The companies Moderna, Amylyx Pharmaceuticals, and Braveheart Bio bagged the biggest biotech funding rounds overall in August ...
Find out what came out of the ESC Congress 2026, from phase 3 successes and failures to earlier-stage programs.
See why investor confidence in cell and gene therapies now depends on execution and supply chain strategy—not strong science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results